The present study proposes a new organization of the Day Hospital unit with several possible pathways defined by PRO. The organization realies on a platform composed of nurses supervised by an IPA and a doctor one day before a treatment in the day hospitalization unit admission, results of PROs collectyed through the CEM@santé application (a French health care application) are reviewed by nurses from the platform and chemotherapy delivery is confirmed. The study is planed in 2 steps. 1. st stage: the current circuit remains unchanged (with systematic medical or nursing validation to confirm chemotherapy administration. Patient satisfaction is collected at each visit to the day hospital unit for chemotherapy. 73 patients will be included in this phase. 2. nd stage: a short circuit is set up. If no contraindications are identified by the plateform with the remote PRO collection, patients will undergo chemotherapy directly the next day (without any medical validation. Patient satisfaction is also collected at each visit to the day hospital unit for chemotherapy. 73 patients will be included in this phase.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
122
Patients enrolled into front phase will be followed in a standard way without any additional procedure except satisfaction questionnaire
Patients included in the post phase will have to complete the "cem@santé" application. If no contraindications are identified by the plateform with the remote PRO collection, patients will undergo chemotherapy directly the next day (without any medical validation).
Centre de lutte contre le cancer Eugène Marquis
Rennes, France
Duration of stay in day hospital unit
Assess the impact on the duration of stay of an anticipated personalization of the stay in HDJ based on a platform of analysis of the PROs collected the day before and the implementation of a short circuit
Time frame: Immediately after the chemotherapy
patient satisfaction
Assessed by EORTC OUT-PATSAT7 ( patient satisfaction with cancer care core questionnaire). satisfaction score between 0 (no satisfaction) and 100 (high satisfaction)
Time frame: Immediately after the chemotherapy
Caregiver satisfaction
Assessed by self questionnaire
Time frame: Month3;Month6
Health related patient quality of life
Assessed by EQ5D-5L (EuroQuol Five Dimension - Five Level Health Survey questionnaire) The scale has five subcomponents with scores from 1 (best) to 5 (worst)
Time frame: Immediately after the chemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.